Research
Professor Antoniou’s main research is the development and application of statistical modelling techniques for addressing clinical questions, and the development of risk prediction tools which are used in clinical practice.
Professor Antoniou heads up a research group of 10 which focuses on two broad areas:
The development and evaluation of risk prediction models for familial breast, ovarian, prostate and other common cancers.
The implementation of BOADICEA into the CanRisk (canrisk.org) user friendly tool for use by healthcare professionals.
The characterisation of cancer risks for genetically susceptible individuals, such as those carrying mutations in the the BRCA1, BRCA2, PALB2, RAD51C and RAD51D genes.